港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系

智通财经

07/02

智通财经APP获悉，复宏汉霖(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。

消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药汉斯状^®(斯鲁利单抗，欧洲商品名：Hetronifly^®)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规临床使用范围。

随着NICE推荐正式落地及NHS挂网的完成，H药成为首个获得NICE批准、可在英格兰和威尔士用于ES-SCLC治疗的抗PD-1单抗。斯鲁利单抗是一种免疫治疗药物，通过帮助人体自身免疫系统识别并攻击癌细胞发挥作用。该药物此前已获得英国药品和医疗保健产品监管局(MHRA)批准，成为英国首个获批用于ES-SCLC治疗的抗PD-1单抗。

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/hans/news/2648756745"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2648756745\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2648756745?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-07-02 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648756745","market":"sh","top_or_hot":-1,"title":"港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系","media":"智通财经","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/02696\">复宏汉霖</a>(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。</p><p>消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药 汉斯状<sup>®</sup>(斯鲁利单抗，欧洲商品名：Hetronifly<sup>®</sup>)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规临床使用范围。</p><p>随着NICE推荐正式落地及NHS挂网的完成，H药成为首个获得NICE批准、可在英格兰和威尔士用于ES-SCLC治疗的抗PD-1单抗。斯鲁利单抗是一种免疫治疗药物，通过帮助人体自身免疫系统识别并攻击癌细胞发挥作用。该药物此前已获得英国药品和医疗保健产品监管局(MHRA)批准，成为英国首个获批用于ES-SCLC治疗的抗PD-1单抗。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 复宏汉霖(02696)早盘涨近12% 汉斯状®获英国NICE推荐正式纳入NHS报销体系\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-02 11:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1462167.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，复宏汉霖(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药 汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1462167.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HK0000165453.HKD","symbol_name":"华夏精选大中华科技基金 A类港币","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1462167.html","article_id":"2648756745","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648756745","pubTimestamp":1782961934,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，复宏汉霖早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国与公司近日宣布，H药 汉斯状已获英国国家卫生与临床优化研究所推荐正式纳入英格兰和威尔士国家医疗服务体系常规临床使用范围。随着NICE推荐正式落地及NHS挂网的完成，H药成为首个获得NICE批准、可在英格兰和威尔士用于ES-SCLC治疗的抗PD-1单抗。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","BK4588":"碎股","BK4023":"应用软件","02696":"复宏汉霖","BK4585":"ETF&股票定投概念","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","BK1161":"生物科技","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","BK4543":"AI","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","VXUS":"国际股票ETF-Vanguard","NICE":"NICE系统","BK4566":"资本集团"},"translate_title":"Hong Kong stock changes | Henlius (02696) rose nearly 12% in early trading Hans shape ® Recommended by UK NICE and formally incorporated into NHS reimbursement system","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1.5,"NICE":1.5,"VXUS":1.5},"content_text":"智通财经APP获悉，复宏汉霖(02696)早盘涨近12%，截至发稿，涨7.07%，报68.95港元，成交额5273.15万港元。消息面上，据复宏汉霖官微消息，Accord Healthcare英国(简称“Accord”)与公司近日宣布，H药 汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)已获英国国家卫生与临床优化研究所(NICE)推荐正式纳入英格兰和威尔士国家医疗服务体系(NHS)常规临床使用范围。随着NICE推荐正式落地及NHS挂网的完成，H药成为首个获得NICE批准、可在英格兰和威尔士用于ES-SCLC治疗的抗PD-1单抗。斯鲁利单抗是一种免疫治疗药物，通过帮助人体自身免疫系统识别并攻击癌细胞发挥作用。该药物此前已获得英国药品和医疗保健产品监管局(MHRA)批准，成为英国首个获批用于ES-SCLC治疗的抗PD-1单抗。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"2","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}